Beta Bionics (BBNX) Operating Income (2024 - 2026)

Beta Bionics has disclosed Operating Income across 3 years of filings, most recently posting -$24.3 million for Q1 2026.

• Operating Income for Q1 2026 came in at -$24.3 million, down 30.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$77.3 million (down 42.01% YoY), and the FY2025 annual result was -$71.7 million, down 58.41% from the prior year.
• Operating Income came in at -$24.3 million for Q1 2026 at Beta Bionics, down from -$16.1 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$9.5 million in Q1 2024 to a low of -$24.3 million in Q1 2026.
• The 3-year median for Operating Income is -$16.1 million (2025), against an average of -$15.7 million.
• Peak annual rise in Operating Income reached 23.68% in 2025, while the deepest fall reached 97.21% in 2025.
• Beta Bionics' Operating Income stood at -$13.0 million in 2024, then declined by 23.68% to -$16.1 million in 2025, then tumbled by 50.53% to -$24.3 million in 2026.
• The last three Operating Income figures came in at -$24.3 million (Q1 2026), -$16.1 million (Q4 2025), and -$17.0 million (Q3 2025), per Business Quant data.